Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2025 10:23 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag PharmNovo erhåller positivt utlåtande från FDA inför planerad IND-ansökan om fas 2a-studie

STOCKHOLM, SVERIGE 12 mars 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar att portföljbolaget PharmNovo erhöll positiv återkoppling rörande bolagets längst framskridna...
March 12, 2025 10:23 ET | Source: Karolinska Development AB (publ)

Karolinska Development's portfolio company PharmNovo receives positive FDA feedback prior to IND application for Phase 2a trial

STOCKHOLM, SWEDEN – March 12, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that portfolio company PharmNovo received positive feedback regarding its most advanced drug...
February 25, 2025 03:10 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag AnaCardio inkluderar den första patienten i en fas 2a-studie med läkemedelskandidaten AC01

STOCKHOLM, SVERIGE 25 februari 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget AnaCardio har doserat den första patienten i den andra delen av den kliniska...
February 25, 2025 03:10 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company AnaCardio includes first patient in a phase 2a study of its drug candidate AC01

STOCKHOLM, SWEDEN February 25, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has dosed the first patient in the phase 2a part of the...
February 18, 2025 08:17 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag Promimic publicerar positiva resultat som visar reducerad bakterietillväxt på HAnano Surface

STOCKHOLM, SVERIGE 18 februari 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Promimic har publicerat positiva resultat som visar en reduktion av...
February 18, 2025 08:17 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portfolio company Promimic publishes positive results on reduction of bacteria growth on HAnano Surface

STOCKHOLM, SWEDEN, February 18 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of...
February 14, 2025 02:00 ET | Source: Karolinska Development AB (publ)

Bokslutskommuniké för januari – december 2024

STOCKHOLM – den 14 februari 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) publicerar idag sin bokslutskommuniké för januari – december 2024. Den fulla rapporten är tillgänglig på bolagets...
February 14, 2025 02:00 ET | Source: Karolinska Development AB (publ)

Year-end Report - January-December 2024

STOCKHOLM – 14 February 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Year-end Report January-December 2024. The full report is available on the Company's website. ...
January 30, 2025 02:50 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag Dilafor avancerar tafoxiparin efter framgångsrika möten med FDA och europeiska läkemedelsmyndigheter

STOCKHOLM, SVERIGE 30 januari 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Dilafor framgångsrikt genomfört rådgivande möten med den amerikanska...
January 30, 2025 02:50 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company Dilafor advances tafoxiparin following successful meetings with FDA and European regulatory authorities

STOCKHOLM, SWEDEN – January 30, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has successfully completed regulatory meetings with the U.S....